The international industry for Active Pharmaceutical Ingredient (API) suppliers is a complex landscape, encompassing numerous locations. The People’s Republic of China currently leads the production of APIs, trailing India, which is a significant player in both off-patent API provision . European businesses, particularly in countries like Germany